Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus‐associated oropharyngeal squamous cell carcinoma
dc.contributor.author | Hawkins, Peter G. | |
dc.contributor.author | Mierzwa, Michelle L. | |
dc.contributor.author | Bellile, Emily | |
dc.contributor.author | Jackson, William C. | |
dc.contributor.author | Malloy, Kelly M. | |
dc.contributor.author | Chinn, Steven B. | |
dc.contributor.author | Spector, Matthew E. | |
dc.contributor.author | Shuman, Andrew G. | |
dc.contributor.author | Stucken, Chaz L. | |
dc.contributor.author | McLean, Scott A. | |
dc.contributor.author | Bradford, Carol R. | |
dc.contributor.author | Prince, Mark E. | |
dc.contributor.author | Carey, Thomas E. | |
dc.contributor.author | Worden, Francis P. | |
dc.contributor.author | Swiecicki, Paul L. | |
dc.contributor.author | Taylor, Jeremy M. G. | |
dc.contributor.author | Wolf, Gregory T. | |
dc.contributor.author | Eisbruch, Avraham | |
dc.contributor.author | Casper, Keith A. | |
dc.date.accessioned | 2019-04-02T18:10:24Z | |
dc.date.available | 2020-06-01T14:50:01Z | en |
dc.date.issued | 2019-04 | |
dc.identifier.citation | Hawkins, Peter G.; Mierzwa, Michelle L.; Bellile, Emily; Jackson, William C.; Malloy, Kelly M.; Chinn, Steven B.; Spector, Matthew E.; Shuman, Andrew G.; Stucken, Chaz L.; McLean, Scott A.; Bradford, Carol R.; Prince, Mark E.; Carey, Thomas E.; Worden, Francis P.; Swiecicki, Paul L.; Taylor, Jeremy M. G.; Wolf, Gregory T.; Eisbruch, Avraham; Casper, Keith A. (2019). "Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus‐associated oropharyngeal squamous cell carcinoma." Head & Neck 41(4): 857-864. | |
dc.identifier.issn | 1043-3074 | |
dc.identifier.issn | 1097-0347 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/148352 | |
dc.description.abstract | BackgroundThe purpose of this study was to evaluate the AJCC eighth edition clinical staging system for human papillomavirus (HPV)‐associated oropharyngeal squamous cell carcinoma and to further understand how clinical stage and smoking history affect oncologic outcomes. The purpose of this study was to present the understanding of how clinical stage and smoking history affect oncologic outcomes in human papillomavirus (HPV)‐associated oropharyngeal squamous cell carcinoma (SCC) is critical for selecting patients for treatment deintensification.MethodsKaplan‐Meier and Cox regression were used to evaluate overall survival (OS), locoregional recurrence‐free survival (LRFS), and distant recurrence‐free survival (DRFS). Concordance statistics (C‐indices) were used to compare discriminating ability.ResultsThe OS and DRFS but not LRFS were significantly distributed using the American Joint Committee on Cancer (AJCC) seventh and eighth editions criteria. The C‐indices for OS, LRFS, and DRFS were 0.57, 0.54, and 0.60, respectively, using the AJCC seventh edition, and 0.63, 0.53, and 0.65, respectively, using the AJCC eighth edition. On multivariate analysis, 1 + pack‐year smoking history correlated with OS (hazard ratio [HR] 1.96; 95% confidence interval [CI] 1.2‐3.1; P < .01) but not LRFS or DRFS.ConclusionThese results support implementation of the AJCC eighth edition for HPV‐associated oropharyngeal SCC. Clinical stage may be more important than smoking history in selection for deintensification. | |
dc.publisher | John Wiley & Sons, Inc | |
dc.subject.other | oropharyngeal squamous cell carcinoma | |
dc.subject.other | American Joint Committee on Cancer | |
dc.subject.other | clinical staging | |
dc.subject.other | human papillomavirus (HPV) | |
dc.subject.other | smoking | |
dc.title | Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus‐associated oropharyngeal squamous cell carcinoma | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Otolaryngology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/148352/1/hed25336_am.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/148352/2/hed25336.pdf | |
dc.identifier.doi | 10.1002/hed.25336 | |
dc.identifier.source | Head & Neck | |
dc.identifier.citedreference | Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010; 363 ( 1 ): 24 ‐ 35. | |
dc.identifier.citedreference | Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29 ( 32 ): 4294 ‐ 4301. | |
dc.identifier.citedreference | Reimers N, Kasper HU, Weissenborn SJ, et al. Combined analysis of HPV‐DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 2007; 120 ( 8 ): 1731 ‐ 1738. | |
dc.identifier.citedreference | Masterson L, Moualed D, Liu ZW, et al. De‐escalation treatment protocols for human papillomavirus‐associated oropharyngeal squamous cell carcinoma: a systematic review and meta‐analysis of current clinical trials. Eur J Cancer. 2014; 50 ( 15 ): 2636 ‐ 2648. | |
dc.identifier.citedreference | Marur S, Li S, Cmelak AJ, et al. E1308: Phase II trial of induction chemotherapy followed by reduced‐dose radiation and weekly cetuximab in patients with HPV‐associated resectable squamous cell carcinoma of the oropharynx ‐ ECOG‐ACRIN Cancer Research Group. J Clin Oncol. 2017; 35 ( 5 ): 490 ‐ 497. | |
dc.identifier.citedreference | Huang SH, Perez‐Ordonez B, Liu FF, et al. Atypical clinical behavior of p16‐confirmed HPV‐related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys. 2012; 82 ( 1 ): 276 ‐ 283. | |
dc.identifier.citedreference | Huang SH, Perez‐Ordonez B, Weinreb I, et al. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV‐related oropharyngeal cancer. Oral Oncol. 2013; 49 ( 1 ): 79 ‐ 85. | |
dc.identifier.citedreference | Trosman SJ, Koyfman SA, Ward MC, et al. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy. JAMA Otolaryngol Head Neck Surg. 2015; 141 ( 5 ): 457 ‐ 462. | |
dc.identifier.citedreference | O’Sullivan B, Huang SH, Siu LL, et al. Deintensification candidate subgroups in human papillomavirus‐related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol. 2013; 31 ( 5 ): 543 ‐ 550. | |
dc.identifier.citedreference | O’Sullivan B, Huang SH, Perez‐Ordonez B, et al. Outcomes of HPV‐related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother Oncol. 2012; 103 ( 1 ): 49 ‐ 56. | |
dc.identifier.citedreference | Vainshtein JM, Spector ME, McHugh JB, et al. Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus‐associated oropharyngeal cancer. Oral Oncol. 2014; 50 ( 5 ): 513 ‐ 519. | |
dc.identifier.citedreference | Gillison ML, Zhang Q, Jordan R, et al. Tobacco smoking and increased risk of death and progression for patients with p16‐positive and p16‐negative oropharyngeal cancer. J Clin Oncol. 2012; 30 ( 17 ): 2102 ‐ 2111. | |
dc.identifier.citedreference | Maxwell JH, Kumar B, Feng FY, et al. Tobacco use in human papillomavirus‐positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res. 2010; 16 ( 4 ): 1226 ‐ 1235. | |
dc.identifier.citedreference | Porceddu SV, Milne R, Brown E, et al. Validation of the ICON‐S staging for HPV‐associated oropharyngeal carcinoma using a pre‐defined treatment policy. Oral Oncol. 2017; 66: 81 ‐ 86. | |
dc.identifier.citedreference | Würdemann N, Wagner S, Sharma SJ, et al. Prognostic impact of AJCC/UICC 8th edition new staging rules in oropharyngeal squamous cell carcinoma. Front Oncol. 2017; 7: 129. | |
dc.identifier.citedreference | Amin MB, Edge SB, Greene F, eds. AJCC Cancer Staging Manual. Eighth Ed. New York, NY, Springer, 2017. | |
dc.identifier.citedreference | O’Sullivan B, Huang SH, Su J, et al. Development and validation of a staging system for HPV‐related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON‐S): a multicentre cohort study. Lancet Oncol. 2016; 17 ( 4 ): 440 ‐ 451. | |
dc.identifier.citedreference | Huang SH, Xu W, Waldron J, et al. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus‐related oropharyngeal carcinomas. J Clin Oncol. 2015; 33 ( 8 ): 836 ‐ 845. | |
dc.identifier.citedreference | Dahlstrom KR, Calzada G, Hanby JD, et al. An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair. Cancer. 2013; 119 ( 1 ): 81 ‐ 89. | |
dc.identifier.citedreference | Spector ME, Gallagher KK, Bellile E, et al. Patterns of nodal metastasis and prognosis in human papillomavirus‐positive oropharyngeal squamous cell carcinoma. Head Neck. 2014; 36 ( 9 ): 1233 ‐ 1240. | |
dc.identifier.citedreference | Ward MJ, Mellows T, Harris S, et al. Staging and treatment of oropharyngeal cancer in the human papillomavirus era. Head Neck. 2015; 37 ( 7 ): 1002 ‐ 1013. | |
dc.identifier.citedreference | Edge SB, Byrd DR, Compton C, Fritz AG, Greene FL, Trotti A III, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY, Springer, 2010. | |
dc.identifier.citedreference | Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus‐positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008; 100 ( 4 ): 261 ‐ 269. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.